SEC Form 4

FORM 4 [ ] Check this box if no longersubject to Section 16. Form 4 or Form5 obligations may continue.See Instruction 1(b). (Print or Type Responses) UNITED STATES SECURITIES AND EXCHANGE ~~COMMISSIONWashington~~COMMISSION Washington, D.C. ~~20549STATEMENT~~20549 STATEMENT OF CHANGES IN BENEFICIAL ~~OWNERSHIPFiled~~OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public ~~UtilityHolding~~Utility Holding Company Act of 1935 or Section 30(fh) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, ~~2005~~2005Estimated ~~Estimated~~ average ~~burden~~burdenhours ~~hours~~ per response. . . . . 0.5

1. Name and Address of Reporting Person*Norton, Robert W. (Last) (First) (Middle)Pfizer Inc. Att: Corporate Secretary235 East 42nd Street(Street)New York, NY 10017 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading SymbolPfizer Inc (PFE)3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) 4. Statement for (Month/Year) December 31, 2002 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person(s) to Issuer(Check all applicable) Director 10% Owner X Officer OtherOfficer/OtherDescription Senior Vice President7. Individual or Joint/Group Filing (Check Applicable Line) X Individual Filing Joint/Group Filing

1. Name and Address of Reporting Person^* Norton, Robert W. (Last) (First) (Middle) Pfizer Inc. Att: Corporate Secretary 235 East 42nd Street (Street) New York, NY 10017 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Pfizer Inc (PFE)		6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer Other Senior Vice President 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary)	4. Statement for Month/Day/Year January 15, 2003 5. If Amendment, Date of Original (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code and Voluntary Code (Instr. 8) Code | V 4. Securities Acquired (A) or Disposed (D) Of (Instr. 3, 4, and 5) Amount | A/D | Price 5. Amount of Securities Beneficially Owned ~~following~~Following ~~reported transaction~~ReportedTransaction(s) (Instr. 3 and 4) 6. Owner- ship Form: Direct(D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. (over)SEC 1474 (39-9902)

Norton, Robert W. - ~~December~~January 3115, ~~2002~~2003

Form 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conver- sion or Exercise Price of Deri- vative Security	3. Transaction Date (Month/ Day/ Year)	43A. ~~Transaction~~Deemed ~~Code~~Execution ~~and~~Date, ~~Voluntary~~if ~~(V)~~any ~~Code~~ (~~Instr.8)Code~~Month/ \|Day/ VYear)	54. ~~Number~~Transaction ofCode ~~Derivative~~and ~~Securities~~Voluntary ~~Acquired~~ (AV) orCode ~~Disposed~~ (~~D) Of (~~Instr.8) ~~3,4~~Code ~~and~~\| 5)V	65. ~~Date~~Number ~~Exercisable(DE)~~of ~~and~~Derivative ~~Expiration~~Securities ~~Date(ED)~~Acquired (~~Month/Day/Year~~A) or Disposed (DED) \|Of (EDInstr. 3,4 and 5)	76. ~~Title~~Date Exercisable(DE) and ~~Amount~~Expiration ofDate(ED) ~~Underlying~~(Month/Day/Year) ~~Securities~~ (~~Instr.~~DE) 3\| ~~and 4~~(ED)	87. ~~Price~~Title and Amount of ~~Derivative~~Underlying ~~Security~~Securities (Instr.5 3 and 4)	98. ~~Number~~Price of Derivative ~~Securities~~Security ~~Beneficially Owned Following Reported Transaction~~(~~s) (~~Instr.45)	109.~~Owner-shipForm~~ ~~ofDeriv-ativeSecurity:Direct~~Number of Derivative Securities Beneficially Owned Following Reported Transactions (DInstr.4)~~orIndirect(I)~~	1110.Owner-shipForm ~~Nature of Indirect Beneficial Ownership~~ ofDeriv-ativeSecurity:Direct(D)orIndirect(I)(Instr.4)	11. Nature of Indirect Beneficial Ownership (Instr.4)
Phantom Stock Units (SSP)	1-for-1	1201/3115/~~2002~~2003	~~A \|~~	(A) 34\|	~~Immed. \|~~ (1A) 119	~~Common~~Immed. ~~Stock~~\| ~~- 34~~(1)	~~$30.57~~Common Stock - 119	~~23,136~~$30.45	D23,255	D

Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, ~~See~~see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are ~~notrequired~~not required to respond unless the form displays a currently valid OMB number. ~~/s/~~ By: Margaret M. Foran for Robert W. Norton ~~________________________________~~ 01-0216-2003 ** Signature of Reporting Person ~~DateBy~~Date ~~Margaret~~Power M.of ~~Foran~~Attorney ~~forRobert W. Norton~~ Page ~~2SEC 1474 (3-99)~~2

Norton, Robert W. - ~~December~~January 3115, ~~2002~~2003

Form 4 (continued)

FOOTNOTE Descriptions for Pfizer Inc (PFE) Form 4 - ~~December~~January 3115, ~~2002~~2003 Robert W. NortonPfizer Inc. Att: Corporate Secretary235 East 42nd StreetNew York, NY ~~10017Explanation~~10017 Explanation of responses: (1) These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service.

Page 3

Filing Compare · NORTON ROBERT W